US president Donald Trump's imposition of import tariffs on key goods underscores his 'Made in America' agenda. While pharmaceuticals remain exempt for now, Trump has signaled potential future tariffs specifically targeting the sector.
US president Donald Trump's imposition of import tariffs on key goods underscores his 'Made in America' agenda. While pharmaceuticals remain exempt for now, Trump has signaled potential future tariffs specifically targeting the sector.